@LuisCardenasMx Me da risa como te ofenden en lugar de ver la triste realidad de México que nos afecta a todos. Ánimo Luis tú muy bien con tus comentarios tan certeros
🧠🏃♂️ Exercise is now part of adjuvant colon cancer care. Yes, officially.
ESMO colon cancer guidelines now recommend
structured exercise programmes alongside chemotherapy in Stage II (high-risk) and Stage III colon cancer.
This is not lifestyle advice.
This is evidence-based oncology care 👇
🟣 Where does exercise fit?
🔹 Stage III colon cancer
🔹 High-risk Stage II colon cancer
🔹 During adjuvant chemotherapy + follow-up
🟣 Strength of evidence
📊 Level II evidence
📌 Grade B recommendation
📌 MCBS A score
🟣 Why this matters clinically
🧬 Improved disease-free survival
💪 Better treatment tolerance
😌 Reduced fatigue and QoL decline
📉 Lower recurrence signals
🟣 Key takeaway
Exercise is no longer optional advice.
It is part of standard adjuvant management in colon cancer.
🔖 Save this for clinics and MDTs
📖 Full guideline in comment ⬇️
#OncoTwitter #MedTwitter #ColonCancer #GIOncology
@myesmo@esmo_open@asco@OncoAlert
Among women under 50, those with the highest ultraprocessed food intake had 45% higher odds of early-onset colorectal conventional adenomas versus those with the lowest intake; no significant association was seen for serrated lesions. https://t.co/ec5MzECkh2
Among women under 50, those with the highest ultraprocessed food intake had 45% higher odds of early-onset colorectal conventional adenomas versus those with the lowest intake; no significant association was seen for serrated lesions. https://t.co/liASoymX9v
Viewpoint: The rise in early-onset cancers in individuals under 50 may be explained by accelerated biological aging, with aging and cancer sharing common mechanisms. https://t.co/GrMGEt2mZI
Recurrencia de Carcinoma Mamario Ipsilateral: ¿Recurrencia Verdadera o Nuevo Primario? Un Estudio Clinicopatológico y Molecular. https://t.co/eImmB4ZxjX vía @docguide
#AlAire 🎙️
La Dra. Carolina Blanco (@yazbcov), médico internista y oncóloga médico del hospital ABC, habla con @LuisCardenasMx🧑💻sobre los tipos de cáncer.
102.5 FM 📻
https://t.co/4QSrM9hR6i💻
Exactitud de la inteligencia artificial en la detección de metástasis óseas tumorales: una revisión sistemática y un meta-análisis. https://t.co/9dOSqaBBwJ vía @docguide
Altas tasas de respuesta con encorafenib de primera línea más cetuximab y quimioterapia en cáncer colorrectal metastásico con mutación BRAF V600E https://t.co/1yHJMRzXfp vía @docguide
Current landscape of BRAF-V600E metastatic CRC management in Latin America: an expert Latin American panel’s recommendations - ecancer https://t.co/mUNqbNcacU